NDC 50090-0295-01 - KENALOG-10
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0295
- Requested NDC
- 50090-0295-01
- Package NDCs from labels
- 50090-0295-1, 50090-0295-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| KENALOG-10 - A-S Medication Solutions | A-S Medication Solutions | 2026-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-03-17 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
| 2023-03-17 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
| 2023-01-30 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
| 2023-01-30 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0295-1 | KENALOG-10 | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 18 | |
| 50090-0295-1 | KENALOG-10 | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION, SUSPENSION | 5 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0295 | KENALOG-10 (TRIAMCINOLONE ACETONIDE) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS] | 18 | Current NDC, Legacy NDC, 2 package rows | 20230318_653ec195-0966-478d-be47-6b1ff158e111.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0295-1 | ML - Milliliter | 50090-0295 | bf8017ef-4e4e-49c0-9383-71e04e84cf4a | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | 6OZP39ZG8H K679OBS311 |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Nitrogen | NITROGEN | Linde Inc. | 11f1ea16-93eb-4994-ba96-d0d7519015e2 | 2026-07-16 | N762921K75 | |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc. | 3d495acf-8085-4aaa-8fc5-594b88c25c21 | 2026-07-13 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sportpharm LLC | 20c1234b-6749-422d-9420-9d5a98f5f30a | 2026-07-13 | Adverse reactions | F446C597KA |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Ascend Laboratories, LLC | ccca8660-124e-4220-8d87-4b9aeecbda7d | 2026-07-13 | Adverse reactions | F446C597KA |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Encube Ethicals, Inc. | db87426f-124c-4ea9-bb15-fc3a0da10a4e | 2026-07-07 | Adverse reactions | F446C597KA |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Encube Ethicals, Inc. | 6a31a0c3-2b6e-40e3-b5ea-5c665afd3567 | 2026-07-06 | Adverse reactions | F446C597KA |
| Retaine CMC | CARBOXYMETHYLCELLULOSE SODIUM | OCuSOFT LLC | a3698c71-0c80-4246-be52-5e7d96f6c540 | 2026-07-06 | Warnings | K679OBS311 |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55820ff9-7b4b-2bce-e063-6394a90a8b43 | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55806cb8-cf92-c4e5-e063-6394a90aaa2d | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 5581d8e5-4105-e9da-e063-6394a90a316e | 2026-06-30 | Warnings | 451W47IQ8X |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | LKG8494WBH |
| MCAS Support | APIS MELLIFICA, ANTIMONIUM CRUDUM, ASCORBICUM ACIDUM, BOVISTA, CARBOLICUM ACIDUM, CHAMOMILLA, CORTISONE ACETICUM, GINKGO BILOBA, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, NATRUM MURIATICUM, QUERCETIN, RHUS TOX, SCUTELLARIA LATERIFLORA, STOMACH (SUIS), URTICA URENS | Deseret Biologicals, Inc. | af3d5f8f-6f24-4045-8730-c776ff54bcc4 | 2026-06-24 | Warnings | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 089a8449-7810-48ec-b327-494f058c3348 | 2026-06-22 | Adverse reactions | F446C597KA |
| Rohto Cool Relief | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | dc8f1ff3-87ae-47ca-815f-5a0e34f8cf30 | 2026-06-19 | Warnings | 6OZP39ZG8H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.